From Casetext: Smarter Legal Research

Pharma v. Ranbaxy

United States Court of Appeals, Federal Circuit
Nov 6, 2007
255 F. App'x 512 (Fed. Cir. 2007)

Opinion

No. 2007-1199.

November 6, 2007.


ORDER

Defendants-Appellants Ranbaxy Inc., Ranbaxy Pharmaceuticals Inc., and Ranbaxy Laboratories Limited and Plaintiffs-Appellees Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals, Inc., having filed a consented Motion for an Order remanding the pending action to the District Court for further action by that court to effectuate a contingent settlement, and this Court having considered the consented Motion and for good cause shown, it is hereby,

ORDERED that the Motion is GRANTED. This case is remanded to the District Court.


Summaries of

Pharma v. Ranbaxy

United States Court of Appeals, Federal Circuit
Nov 6, 2007
255 F. App'x 512 (Fed. Cir. 2007)
Case details for

Pharma v. Ranbaxy

Case Details

Full title:ASTELLAS PHARMA, INC. and Boehringer Ingelheim Pharmaceuticals, Inc.…

Court:United States Court of Appeals, Federal Circuit

Date published: Nov 6, 2007

Citations

255 F. App'x 512 (Fed. Cir. 2007)